Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Embracing Future HoldingsSGX:8YY PS Ratio is 19.50 as of Aug. 08, 2026, which is 160% above its 10-year median of 7.49. The stock has 5 warning signs investors should review. Among 200 Medical Diagnostics & Research companies, Embracing Future Holdings ranks worse than 92.5% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Embracing Future Holdings's share price is S$0.039.
Embracing Future Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was S$0.00. Hence, Embracing Future Holdings's PS Ratio for today is 19.50.
The historical rank and industry rank for Embracing Future Holdings's PS Ratio or its related term are showing as below:
SGX:8YY'
s PS Ratio Range Over the Past 10 Years
Min: 1.56 Med: 7.49 Max: 48.5
Current: 19.5
During the past 11 years, Embracing Future Holdings's highest PS Ratio was 48.50. The lowest was 1.56. And the median was 7.49.
SGX:8YY's PS Ratio is ranked worse than 92.5% of 200
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.815
vs SGX:8YY: 19.50
During the past 11 years, Embracing Future Holdings's highest 3-Year average Revenue per Share Growth Rate was 60.40% per year. The lowest was -51.90% per year. And the median was -3.50% per year.
Embracing Future Holdings (SGX:8YY) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Embracing Future Holdings PS Ratio Related Terms
Embracing Future Holdings PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Embracing Future Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embracing Future Holdings PS Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Embracing Future Holdings's PS Ratio distribution charts can be found below:
* The bar in red indicates where Embracing Future Holdings's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Embracing Future Holdings's Share Price of today is S$0.039. Embracing Future Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was S$0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Embracing Future Holdings (SGX:8YY) has a PS Ratio of 19.50 as of Aug. 08, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Embracing Future Holdings and its competitors. This is 160% above median its historical median of 7.49. Over the past decade, Embracing Future Holdings' PS Ratio has ranged from 1.56 to 48.50. According to the industry distribution chart, Embracing Future Holdings ranks #185 out of 200 companies in the Medical Diagnostics & Research industry, placing it in the top 92.5%.
Is Embracing Future Holdings' PS Ratio too high?
Embracing Future Holdings' current PS Ratio of 19.50 is 160% above median its 10-year median of 7.49. Over the past 10 years, this metric has ranged from a low of 1.56 to a high of 48.50. The Medical Diagnostics & Research industry median PS Ratio is 2.82. Embracing Future Holdings' value of 19.50 is 592.7% above this industry median. Based on the distribution chart, Embracing Future Holdings ranks #185 out of 200 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Embracing Future Holdings' PS Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Embracing Future Holdings ranks #185 out of 200 companies for PS Ratio. This places Embracing Future Holdings in the lower half of its industry. The industry median PS Ratio is 2.82. Embracing Future Holdings' value of 19.50 is 592.7% above this benchmark. Historically, Embracing Future Holdings' own PS Ratio has ranged from 1.56 to 48.50 over the past decade. While the company's 10-year median is 7.49 vs. the industry median of 2.82, Embracing Future Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Diagnostics & Research company?
The median PS Ratio among Medical Diagnostics & Research companies is 2.82, based on 200 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Embracing Future Holdings's current PS Ratio of 19.50 is 592.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Embracing Future Holdings and its competitors. For the Medical Diagnostics & Research industry, the median PS Ratio is 2.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embracing Future Holdings's current PS Ratio is 19.50, which is 160% above median its own 10-year median of 7.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embracing Future Holdings stock overvalued right now?
Embracing Future Holdings (SGX:8YY) has a current PS Ratio of 19.50. The current PS Ratio is 19.50, which is 160% above median its 10-year median of 7.49 and 592.7% above the Medical Diagnostics & Research industry median of 2.82. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Embracing Future Holdings (SGX:8YY), the current PS Ratio is 19.50 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Embracing Future Holdings Ltd is engaged in technology development, technology transfer, marketing, sales, and distribution of biomedical technology, life, and medicine science-related products and services, and investment holding. The company's business segments are: Cancer, Infectious Diseases, E-sports, Advertising, and Corporate. The company generates the majority of its revenue from the E-sports segment, which involves identifying and assessing potential collaboration partners, technology, digital platforms, products, and services related to E-Sports. Its operations are spread across Singapore, Japan, China, Europe, Hong Kong, Thailand, Malaysia, and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:8YY has been successfully added to your 
